State-of-the-art Bayesian platform for computational oncology

Make better decisions by quantifying uncertainty

Our platform makes predictions and supports decisions for individuals, treatments, subgroups, and target populations. We use the latest advances in Bayesian computation, Probabilistic Programming, and Decision Theory to bridge the gap between data, models, and the decision makers.

Interpretability.png

Interpretability

Our models are generative, transparent, explainable, and testable. In contrast to black box methods, we know what these models are doing.

PredictiveAccuracy.png

Predictive Accuracy

In-sample predictions are easy. Our models make well calibrated predictions out of sample: for a new patient, a new study arm, and even a new trial.

Algorithm (1).png

Algorithms

Recent advances in computational statistics allow us to tackle models previously thought too difficult due to non-linearities and the number of unknowns.

SmallData.png

Clinical Data

Our models work well in the small data regime, such as in platform trials in Oncology and Rare Diseases, where we need to take advantage of information external to the clinical trial.

Generable Website Design2.png

Joint Survival Models

Linking the model for the hazard with     

sub-models for individual biomarkers.   

Joint models for comorbidities.

Generable Website Design.png

Pharmacometric Models

Using Ordinary Differential Equation (ODE) solvers we encode how the drug moves through different parts of the body.

Genomic Models

Retain proper uncertainties and produce more accurate predictions than popular tools like Lasso and PCA.

Want to learn more?